Monte Rosa Therapeutics, Inc. · NASDAQ:GLUE
New Enterprise Associates 17, L.P. reported a 7.90% stake in Monte Rosa Therapeutics, Inc. (Schedule 13D/A)
Event Jul 1, 2026 · Filed Jul 6, 2026
New Enterprise Associates 17, L.P. reported a 7.90% stake in Monte Rosa Therapeutics, Inc., 6,692,298 shares, with active intent on Jul 1, 2026. Filed Jul 6, 2026 (Schedule 13D/A).
- Stake
- 7.90%
- Shares
- 6,692,298
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 12 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| New Enterprise Associates 17, L.P. | 7.90% | 6,692,298 |
| NEA Partners 17, L.P. | 7.90% | 6,692,298 |
| NEA 17 GP, LLC | 7.90% | 6,692,298 |
| Anthony A. Florence, Jr. | 7.90% | 6,692,298 |
| Mohamad H. Makhzoumi | 7.90% | 6,692,298 |
| Scott D. Sandell | 7.90% | 6,692,298 |
| Forest Baskett | 0% | 0 |
| Ali Behbahani | 0.20% | 135,432 |
| Carmen Chang | 0% | 0 |
| Edward T. Mathers | 0% | 0 |
| Paul Walker | 0% | 0 |
| Rick Yang | 0% | 0 |
Source
Related
- Monte Rosa Therapeutics, Inc.
- New Enterprise Associates 17, L.P.
- Monte Rosa Therapeutics, Inc. shareholders
- Form 4 · Bowen Matthew · Oct 6, 2026
- Schedule 13G/A · Montanova Capital, LLC · Aug 14, 2026
- Schedule 13G · Vestal Point Capital, LP · Aug 14, 2026
- Form 4 · Warmuth Markus · Jul 17, 2026
- Form 4 · Champoux Jennifer · Jul 16, 2026